首页> 外文期刊>Medical hypotheses >Ratio of CD147(high)/CD147(low) in CD4(+) CD25(+) T cells: A potential biomarker for early diagnosis and prediction of response to therapy for autoimmune diseases
【24h】

Ratio of CD147(high)/CD147(low) in CD4(+) CD25(+) T cells: A potential biomarker for early diagnosis and prediction of response to therapy for autoimmune diseases

机译:CD4(+)CD25(+)T细胞中CD147(高)/ CD147(低)的比例:用于早期诊断和对自身免疫疾病治疗的响应的潜在生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Regulatory T cell (Treg cell) is an important immunosuppressive T cell subset and plays a dominant role in maintaining the immune balance in vivo. The function defects in Treg cells have been involved in the pathogenesis of many autoimmune diseases. The detection of Treg cell suppressive function is important for early diagnosis and prediction of response to treatment for autoimmune diseases. The traditional detection of Treg cell suppressive function needs at least 20 mL peripheral blood sample of patients and the results would be got in sixth day, therefore, it could not be widely applied in clinical. However, to find fast and simple detection method is very important. CD147 is a transmembrane protein and its expression is related to Treg cell suppressive function. Recent research has shown that the Treg cells with high CD147 expression have stronger suppressive function than which with low CD147 expression. In this work, we detected the ratio of CD147(high)/CD147(low) in CD4(+)CD25(+) T cells in patients with active AS using fluorescence-activated cell sorter (FACS). The results show the ratio of CD147(high)/CD147(low) decreased obviously in patients with active AS compared with healthy controls, which reflects the suppressive function deficit of Treg cell. In the same time, the detection of the ratio of CD147(high)/CD147(low) needs only 150 mu L peripheral blood sample and the result would be got in 4 h. We therefore hypothesize that the ratio of CD147(high)/CD147(low) is a good indicator for the Treg cell function, and it is especially suitable for early diagnosis and prediction of response to therapy targeted recovering Treg cell function in autoimmune diseases.
机译:调节性T细胞(Treg Cell)是重要的免疫抑制T细胞子集,并在维持体内免疫平衡方面发挥显着作用。 Treg细胞中的功能缺陷已经参与了许多自身免疫疾病的发病机制。检测Treg细胞抑制功能对于早期诊断和预测对自身免疫疾病治疗的反应是重要的。传统的Treg细胞抑制功能检测需要至少20ml患者外周血样品,结果将在第六天获得结果,因此,它不能被广泛应用于临床上。但是,要找到快速而简单的检测方法非常重要。 CD147是跨膜蛋白,其表达与Treg细胞抑制功能有关。最近的研究表明,具有高CD147表达的Treg细胞具有比具有低CD147表达的抑制功能更强。在这项工作中,我们检测到用作荧光激活细胞分选仪(FACS)的活性患者CD47(高)/ CD147(+)CD25(+)T细胞中的CD47(高)/ CD147(+)T细胞的比率。结果表明,与健康对照相比,活性患者的CD147(高)/ CD147(低)的比例明显降低,其反映了Treg细胞的抑制功能缺陷。同时,检测CD147(高)/ CD147(低)的比率仅需要150μmL外周血样品,结果将在4小时内得到。因此,我们假设CD147(高)/ CD147(低)的比例是Treg细胞功能的良好指标,特别适用于对自身免疫疾病中靶向回收Treg细胞功能的早期诊断和预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号